Charity information


The incidence of male cancer is rising rapidly: One man dies every hour from prostate cancer in the UK and testicular cancer is now the most common cancer in men between the ages of 15-44. Everyman works to raise awareness and fund research into testicular and prostate cancer.

Money raised through the campaign will go directly towards supporting research at the ICR focusing on prostate and testicular cancer. Scientists believe studies currently in the pipeline could dramatically reduce the number of men dying from prostate cancer. We are developing new treatments, refining existing treatments and improving diagnostic and screening options. Our work will lead to an improvement in treatment and care for men with prostate cancer.

Among the most exciting prospects is a new drug discovered at the ICR called abiraterone, which was recently tested in 1,200 patients with advanced prostate cancer in 13 countries. Trial leader Professor Johann de Bono says: “This drug improves not only quality of life but survival and very few drugs have done that before, so it’s really quite an important development. ”

Thanks to research at the ICR testicular cancer is already 97 per cent curable. ICR scientists are now focussed on refining existing treatments to reduce their side-effects, while also continuing the search for genes involved in the development and progression of testicular cancer. Their ultimate aim is to identify men at higher risk of the disease and create new, targeted treatments.

Help Everyman in the fight against male cancer. Telephone: 0800 731 9468.

  • Recognising the Aggressive and Non-Aggressive form...

    Many men with non-aggressive forms of prostate cancer do not need treatment and it is inap... More